Conditions: Essential Hypertension Complicated by Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 33
Healthy volunteers: no

Brief summary:
Multicenter, randomized, open-label, parallel-group exploratory study to explore the effects of azilsartan (Azirva), compared with telmisartan, on insulin resistance in participants with essential hypertension complicated by type 2 diabetes mellitus

Detailed description:
The primary objective of the present study is to explore the effects of azilsartan 20 mg, compared with telmisartan 40 mg, once daily orally for 12 weeks on insulin resistance in participants with essential hypertension complicated by type 2 diabetes mellitus.

Arms:
arm 1: Participants will receive azilsartan 20 mg once daily in the morning before or after breakfast. arm 2: Participants will receive telmisartan 40 mg once daily in the morning before or after breakfast.

Interventions: intervention 1: Azilsartan intervention 2: Telmisartan
Intervention descriptions: intervention 1: Azilsartan tablets intervention 2: Telmisartan tablets

Protocol document: